戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 bility to bone metastasis was conferred by a bone marrow-derived cell.
2 epend on T or B lymphocytes, but did require bone marrow derived cells.
3 unts and increased proliferative capacity of bone marrow derived cells.
4 s show the involvement of SphK2 expressed in bone marrow-derived cells.
5 ere mediated by structural cells rather than bone marrow-derived cells.
6 est the restorative function of transplanted bone marrow-derived cells.
7 ists such as imiquimod enhance DNA repair in bone marrow-derived cells.
8 ive IRF3 deficiency in liver parenchymal and bone marrow-derived cells.
9 eotide excision repair genes were studied in bone marrow-derived cells.
10 t was due in large part to loss of S100A9 in bone marrow-derived cells.
11 y radioresistant stromal cells as well as by bone marrow-derived cells.
12 ymal stem cell (MSC) dysfunction in isolated bone marrow-derived cells.
13 ure or in wt mice with circulating Cd39 null bone marrow-derived cells.
14 ctive effect of receptors on radiosensitive, bone marrow-derived cells.
15 n was inhibited in mice that lacked PAF-R in bone marrow-derived cells.
16 ting factor (G-CSF) induces proliferation of bone marrow-derived cells.
17  within radioresistant stromal cells and not bone marrow-derived cells.
18 +)F4/80(-) macrophages, and CD11b(-)F4/80(-) bone marrow-derived cells.
19 constructed with TLR4 only on renal cells or bone marrow-derived cells.
20 in resident cells in the skin rather than by bone marrow-derived cells.
21  is not driven by AhR-dependent signals from bone marrow-derived cells.
22  infection, a phenotype that is localized to bone marrow-derived cells.
23 spleen were dependent on MyD88 expression by bone marrow-derived cells.
24 st in part, on p75 TNF receptor expressed in bone marrow-derived cells.
25 umulation, exosomes were taken up by CD45(+) bone marrow-derived cells.
26 surface of the retina and CXCR4 localized in bone marrow-derived cells.
27 nted into irradiated recipient mice to track bone marrow-derived cells.
28 ion-resistant cells via IL-1beta secreted by bone marrow-derived cells.
29 was greater in chimeras with TLR2 present on bone marrow-derived cells.
30 ry response; however, it was required in non-bone marrow-derived cells.
31 t reperfusion is primarily due to effects on bone marrow-derived cells.
32 chemokines in the recruitment of circulating bone marrow-derived cells.
33 ous renal cells rather than incorporation of bone marrow-derived cells.
34 ly lack or selectively express the A(2A)R on bone marrow-derived cells.
35 rboring the male Y chromosome exclusively in bone marrow-derived cells.
36 induced angiogenesis, and recruit protumoral bone marrow-derived cells.
37 en LC were ablated in adults and replaced by bone marrow-derived cells.
38 ver, CD-160130 had no myelotoxicity on human bone marrow-derived cells.
39  tracked with lung parenchymal cells but not bone marrow-derived cells.
40 cept in bone marrow-derived cells or only in bone marrow-derived cells.
41 aracterized by chronic hypoxia and influx of bone marrow-derived cells.
42 ne system and in irradiated mice lacking all bone marrow-derived cells.
43 esponse observed with aging was dependent on bone marrow-derived cells.
44 disease was due to lack of Fas expression on bone marrow-derived cells.
45 ype controls, an effect that was mediated by bone marrow-derived cells.
46 lpha, and IL-1R function was required on non-bone-marrow-derived cells.
47 grastim alone did not lead to engraftment of bone-marrow-derived cells.
48 atory response involved A2BAR signaling from bone marrow-derived cells, A2BARs located on the lung ti
49           CD11b antibodies further inhibited bone marrow-derived cell adhesion and transmigration to
50 t enhance the survival of MyD88(-/-)-derived bone marrow-derived cells after UV B exposure as was obs
51 nic stem cells, neural stem cells, and adult bone-marrow-derived cells all responded by expressing od
52              Notably, IRF5 deficiency in non-bone marrow-derived cells also contributes to the increa
53                     Tgfbr2 deficiency in the bone marrow-derived cells also reduced the size of previ
54  indicate that sbb2(a) is expressed in non-B bone marrow-derived cells and acts in trans.
55                                              Bone marrow-derived cells and chemokines also play a par
56 1 and CXCR4 contribute to the involvement of bone marrow-derived cells and collaborate with VEGF in t
57 udies reveal an important cross-talk between bone marrow-derived cells and epithelial secretory Panet
58                      Cellular fusion between bone marrow-derived cells and host hepatocytes has been
59        BMHs emerge from fusion between donor bone marrow-derived cells and host hepatocytes.
60               PPARgamma is expressed in most bone marrow-derived cells and influences their function.
61 tive bacteria requires caspase-1 activity in bone marrow-derived cells and interleukin-1 receptor sig
62 stigate the relative contribution of TLR2 on bone marrow-derived cells and intrinsic renal cells, we
63 as dependent on the expression of MMP-9 from bone marrow-derived cells and is most likely contributed
64 FcgammaRIIB is expressed on human and murine bone marrow-derived cells and limits inflammation by sup
65 annus originate exclusively from circulating bone marrow-derived cells and not from locally resident
66 ents indicated that CD59a expression on both bone marrow-derived cells and peripheral tissues played
67 ans, we found FcRn to be highly expressed in bone marrow-derived cells and professional APCs in diffe
68 ity to PIFS is determined by the genotype of bone marrow-derived cells and requires the expression of
69 ication and quantification of populations of bone marrow-derived cells and support the view that macr
70 on have been used to analyze the turnover of bone marrow-derived cells and to demonstrate the critica
71 sease development, CCL17 acts on CCR4(+) non-bone marrow-derived cells, and 3) for inflammatory pain
72 tissues and osteoclastogenic propensities of bone marrow-derived cells, and augmented bone destructio
73 included increases in leukostasis, influx of bone marrow-derived cells, and capillary closure.
74                          Portal fibroblasts, bone marrow-derived cells, and epithelial to mesenchymal
75 otidases of the CD39 family are expressed by bone marrow-derived cells, and purinergic mechanisms mig
76 n the tumor microenvironment, CD11b(+)Gr1(+) bone marrow-derived cells are a predominant source of pr
77 at therapeutic mechanisms underlying various bone marrow-derived cells are due to paracrine effects.
78                                              Bone marrow-derived cells are known to play important ro
79                                              Bone marrow-derived cells are recruited to sites of isch
80                     We here demonstrate that bone marrow-derived cells are the major source of MMP-9
81 is in irradiated WT mice, demonstrating that bone marrow-derived cells are the ultimate source of all
82 ome from clinical use in horses treated with bone-marrow-derived cells are presented together with th
83 example, portal fibroblasts, fibrocytes, and bone-marrow-derived cells, as well as cells derived from
84                 Liver damage was mediated by bone marrow-derived cells because WT mice transplanted w
85                                By exchanging bone marrow-derived cells between CD36-expressing and CD
86 the present study was to investigate whether bone marrow-derived cells (BMCs) can be induced to expre
87                                              Bone marrow-derived cells (BMCs) have been implicated as
88 lative contributions of parenchymal cell and bone marrow-derived cell (BMDC) B7-H1 expression, we gen
89 l versus a recently recognized new candidate bone marrow-derived cell (BMDC).
90     Studies in animal models have shown that bone marrow-derived cells (BMDC) could be involved in th
91                        However, migration of bone marrow-derived cells (BMDC) into the CNS is a margi
92                 Recent findings suggest that bone marrow-derived cells (BMDC) may contribute to tissu
93 nsplantation or organ allograft suggest that bone marrow-derived cells (BMDC) may differentiate into
94                          The mobilization of bone marrow-derived cells (BMDC) to distant tissues befo
95 owth might be promoted by the recruitment of bone marrow-derived cells (BMDC), which include endothel
96 so the recruitment of tumor growth-promoting bone marrow-derived cells (BMDC).
97 he accumulation of transplanted adult GFP(+) bone-marrow-derived cells (BMDC) in the substantia nigra
98            After myocardial infarction (MI), bone marrow-derived cells (BMDCs) are found within the m
99                                    Exogenous bone marrow-derived cells (BMDCs) are promising therapeu
100  However, selective inactivation of A2ARs in bone marrow-derived cells (BMDCs) by transplanting bone
101  radiated and bone marrow transplanted mice, bone marrow-derived cells (BMDCs) fuse with Purkinje neu
102                           Transplanted adult bone marrow-derived cells (BMDCs) have been shown to ado
103 odel that irradiation induces recruitment of bone marrow-derived cells (BMDCs) into the tumors, resto
104      Analysis of developmental plasticity of bone marrow-derived cells (BMDCs) is complicated by the
105  regarding the effects of transplantation of bone marrow-derived cells (BMDCs) on the severity of dia
106                                              Bone marrow-derived cells (BMDCs) participate in the gro
107    Increasing evidence suggests that myeloid bone marrow-derived cells (BMDCs) play a critical role i
108 -derived angiogenic cells (BMDACs) and other bone marrow-derived cells (BMDCs) play important roles i
109 ogenesis is performed by beta(3) integrin on bone marrow-derived cells (BMDCs) recruited to sites of
110        Cell fusion is one mechanism by which bone marrow-derived cells (BMDCs) take on the gene expre
111            Injury induces the recruitment of bone marrow-derived cells (BMDCs) that contribute to the
112  diabetes induces the appearance of abnormal bone marrow-derived cells (BMDCs) that fuse with neurons
113 ry tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs
114 as been shown to enhance the contribution of bone marrow-derived cells (BMDCs) to regenerating skelet
115  oxide synthase (iNOS) on the recruitment of bone marrow-derived cells (BMDCs) to the CBLB after acou
116                          The contribution of bone marrow-derived cells (BMDCs) to tumour neovasculari
117 d a chimeric mouse model in which A(2A)Rs on bone marrow-derived cells (BMDCs) were selectively inact
118 by complex interactions between vascular and bone marrow-derived cells (BMDCs), and neurofibromin reg
119             To determine the contribution of bone marrow-derived cells (BMDCs), we exposed tumor-bear
120                                     However, bone marrow-derived cells (BMDCs), which are frequently
121 o thought to mobilize into blood circulation bone marrow-derived cells (BMDCs), which may subsequentl
122 y pro-angiogenic pathways and recruitment of bone marrow-derived cells (BMDCs).
123 ontrol progenitor recruitment is mediated by bone marrow-derived cells, but is not cell autonomous.
124             Either systemic depletion of all bone marrow-derived cells (by irradiation) or local depl
125 aken together, these data suggest that young bone marrow-derived cells can alleviate renal aging in o
126                            Subpopulations of bone marrow-derived cells can be induced to assume a num
127                                  MMP-14 from bone marrow-derived cells can influence the collagen con
128                                        Adult bone marrow-derived cells can participate in muscle rege
129 l of DMD, have demonstrated that circulating bone marrow-derived cells can participate in skeletal mu
130 ng MOs/MPs or selective targeting of CCR2 in bone marrow-derived cells caused delayed clinical deteri
131 chimeras in which CD80/86- or CD40-deficient bone marrow-derived cells coexist with wild-type (WT) ce
132 isease, which demonstrates that PD-L1 on non-bone marrow-derived cells confers the protective effect.
133 an studies has advanced our knowledge of how bone marrow derived cells contribute to neoangiogenesis.
134     Stimulatory IgG receptors (FcgammaRs) on bone marrow-derived cells contribute to the pathogenesis
135       In this study, we investigated whether bone marrow-derived cells contribute to the renewal of a
136 l FIZZ1 expression, whereas STAT6 present in bone marrow-derived cells contributed to airway eosinoph
137                   However, LTalpha-deficient bone marrow-derived cells contributed to CP formed in CD
138             Bone marrow chimeras showed that bone marrow-derived cells contributed to IL-1R-dependent
139 found that LMP7 in both bone marrow- and non-bone marrow-derived cells contributes to the development
140   Stellate cells, portal myofibroblasts, and bone marrow derived cells converge in a complex interact
141 the JCI, Koh and colleagues assessed whether bone marrow-derived cells could alter their fate under c
142 erefore, our data indicate that whereas some bone marrow-derived cells could induce iNKT cell hypores
143 otein-tagged mouse CD63 expressed in primary bone marrow-derived cell cultures.
144 mice with fluorescent green protein-labeled, bone marrow-derived cells demonstrated conclusively the
145 arrow chimeras showed that Mif expression in bone marrow-derived cells did not affect fibrosis and in
146                          IL-1R deficiency in bone marrow-derived cells did not affect the inflammator
147             Selective ablation of PAR-2 from bone marrow-derived cells did not prevent matriptase-dri
148                     Our results suggest that bone marrow-derived cells differentiated into smooth mus
149  heterogeneous population of tissue-resident bone marrow-derived cells; distinct MC subpopulations ar
150  contrast, Lin and coworkers found that some bone marrow-derived cells do appear to incorporate into
151                 Thus, our data indicate that bone marrow-derived cells do not make a significant cont
152  mice express Axl but that Axl deficiency in bone marrow-derived cells does not affect lesion size, c
153                       Moreover, we show that bone marrow-derived cells drive this process.
154 Gstm1 deletion in the parenchyma, and not in bone marrow-derived cells, drives renal inflammation.
155       Moreover, transplantation of ADFP-null bone marrow-derived cells effectively attenuated atheros
156 These cell types include skeletal myoblasts, bone-marrow derived cells, endothelial progenitors, and
157 ession of protective MHC class II alleles in bone marrow-derived cells establishes robust self-tolera
158                  Furthermore, in vitro these bone marrow-derived cells exhibit - as do pancreatic bet
159                   G-CSF+FL therapy mobilized bone marrow-derived cells exhibiting increased expressio
160 this context, dermal/stromal fibroblasts and bone marrow-derived cells expressed increased levels of
161 ANKL, and with a reduction in the numbers of bone-marrow-derived cells expressing the markers CD11b a
162                                              Bone-marrow-derived cells facilitate tumour angiogenesis
163 n-1 in both retina-resident immune cells and bone marrow-derived cells for beta(1, 3)-glucan-elicited
164                  However, transplantation of bone marrow-derived cells from hepcidin-deficient mice (
165 cells after UV B exposure as was observed in bone marrow-derived cells from MyD88(+/+) mice.
166              This was dependent on MyD88, as bone marrow-derived cells from MyD88(-/-) mice did not i
167                                    Bones and bone marrow-derived cells from PAR1 KO and wild-type (WT
168 as been a call to establish proof that these bone marrow-derived cells function appropriately in thei
169                 This unique plasticity makes bone marrow-derived cells good candidates for cell thera
170            Deficiency of AT(1a) receptors in bone marrow-derived cells had no effect on Ang II-induce
171 n of hybrids between cancer cells and normal bone marrow-derived cells have been advocated as tumor p
172                                              Bone marrow-derived cells have been shown to take on fun
173 Lyn knockout mice repopulated with wild-type bone marrow-derived cells have higher vascular permeabil
174                                              Bone marrow-derived cells have important roles in cancer
175  on the potential of genetic manipulation of bone marrow-derived cells in an attempt to further enhan
176  of pathological roles of various subsets of bone marrow-derived cells in atherosclerosis may lead to
177  the contribution of PPARalpha expression by bone marrow-derived cells in atherosclerosis, male and f
178 ngs provide novel insights about the role of bone marrow-derived cells in ischemic preconditioning an
179  explore the role of endogenous cells versus bone marrow-derived cells in mediating tubule repair.
180            Tumor growth also was affected by bone marrow-derived cells in mice lacking any one or all
181 after 6 mo, there were more FSP-1-expressing bone marrow-derived cells in old-to-old mice compared wi
182 tiation of adipocytes from preadipocytes and bone marrow-derived cells in several species, the relati
183 use bone marrow studies showed that resident bone marrow-derived cells in the cornea can initiate thi
184 te that Wolbachia activates TLR2 on resident bone marrow-derived cells in the corneal stroma to produ
185  predominantly tracked with DAF's absence on bone marrow-derived cells in the graft and required allo
186    Here, we investigated a putative role for bone marrow-derived cells in the induction of epithelial
187               Thus, Ags expressed by the non-bone marrow-derived cells in the liver actively cause CD
188 ein transgenic mice to permit observation of bone marrow-derived cells in the myocardium after acute
189                  Whereas the total number of bone marrow-derived cells in the pancreas decreased over
190 ere, we establish that Nf1 heterozygosity of bone marrow-derived cells in the tumor microenvironment
191                       Expression of MMP-9 by bone marrow-derived cells in the tumor stroma is also cr
192 s mainly organized through the activation of bone marrow-derived cells in various tissues.
193           Addition of Wnt3A into cultures of bone-marrow-derived cells in combination with TGFbeta1,
194                                       GFP(+) bone marrow-derived cells included leukocytes and CD45(-
195 tissue repair and by systemically mobilizing bone marrow-derived cells, including a population that c
196 d in a significant increase in the number of bone marrow-derived cells incorporating into the neovasc
197        In both study cohorts, intracapillary bone marrow-derived cells, indicative of leukostasis, we
198                           Sema 7a expressing bone marrow-derived cells induce lung fibrosis and alter
199 ic mammary tumor cells resulted in increased bone marrow-derived cell infiltration into the lung in t
200 se findings suggest that MMP-9 released from bone marrow-derived cells influences the progression of
201 latency in the bone marrow, the migration of bone marrow derived cells into the circulation, and intr
202  transplantation models, that engraftment of bone marrow-derived cells into functioning LSECs is rout
203 cardiac function improves after injection of bone marrow-derived cells into infarcted regions in anim
204 Remarkably, the transplantation of wild-type bone marrow-derived cells into irradiated PCD mutant mic
205          CXCR4 antagonists reduced influx of bone marrow-derived cells into ischemic retina and stron
206                  Here, infusion of wild-type bone marrow-derived cells into unconditioned, nonirradia
207        These findings indicate that ROCK1 in bone marrow-derived cells is a critical mediator of athe
208 cation, CCR2-dependent infiltration of mouse bone marrow-derived cells is abundant in demyelinating a
209 rafts demonstrate that neovascularization by bone marrow-derived cells is accompanied by the activati
210 studies revealed that PD-L1 expressed on non-bone marrow-derived cells is critical for this resistanc
211  that its expression in both endothelial and bone marrow-derived cells is essential for arteriogenesi
212 ata suggest that activation of the A(2A)R on bone marrow-derived cells is primarily responsible for p
213            We show that a functional TLR4 in bone marrow-derived cells is required for the complete e
214 lity of autocrine stimulation, but influx of bone marrow-derived cells is the major source of increas
215 -) mice were irradiated and repopulated with bone marrow-derived cells isolated from either AT(1a) re
216  DTR-expressing DCs is dominant over control bone marrow-derived cells, leading to small LNs and an o
217 identified that loss of BLT2 expression on a bone marrow-derived cell lineage offers protection again
218           We find that the Gpnmb genotype of bone-marrow derived cell lineages significantly influenc
219                                   Given that bone marrow-derived cells may differentiate into smooth
220  under conditions of stress is influenced by bone marrow-derived cells may provide important insight
221                                      Because bone marrow-derived cells mediate many of the effects of
222 tudies suggest that ROCK1 in macrophages and bone marrow-derived cells mediates atherogenesis.
223 ce, the investigators show that transplanted bone marrow-derived cells migrate to the skin of bone ma
224                                Neither adult bone marrow-derived cells nor fetal liver cells from wil
225     We determined that TGF-beta signaling in bone marrow-derived cells, not keratinocytes, regulates
226      These precursors arose from circulating bone marrow-derived cells of monocytic origin.
227                                              Bone marrow-derived cells of nonmyeloid lineage display
228 e examined the impact of COX-1 deficiency in bone marrow-derived cells on early atherogenesis in the
229  generation de novo of Purkinje neurons from bone marrow-derived cells or by fusion of marrow-derived
230  are ameliorated by replacement of PLXNC1 on bone marrow-derived cells or by genetic deletion of Syt7
231 functional TLR4 in the entire body except in bone marrow-derived cells or only in bone marrow-derived
232  in which up to 5% of myofibers incorporated bone marrow-derived cells over a 16- month period in the
233 he proinflammatory function of JNK1 requires bone marrow-derived cells, particularly mast cells.
234  dynamic and complex pathological process of bone marrow-derived cells playing divergent roles.
235 w transplantation studies showed that Bmx in bone marrow-derived cells plays a critical role in the e
236                             In conclusion, a bone marrow-derived cell population is increased in the
237 othelial progenitor cells are a circulating, bone marrow-derived cell population that appears to part
238                                      Certain bone marrow-derived cell populations, called endothelial
239 , we hypothesized that rat mandible vs. long-bone marrow-derived cells possess different osteogenic p
240 imera studies showed that IRF5 deficiency in bone marrow-derived cells prevents lupus development and
241 tumor-bearing mice to show that host CD13(+) bone marrow-derived cells promote cancer progression via
242 d that absence of p21, either globally or in bone marrow-derived cells, protects against atherosclero
243                  CCR2-dependent migration of bone marrow-derived cells provided the driving force for
244 eriments indicated that IRAK-M expression by bone marrow-derived cells, rather than structural cells,
245       Together, these data suggest that: (1) bone marrow-derived cells represent an effective neuropr
246 gnaling by caspase-1(KO) specifically within bone marrow-derived cells revealed that monocytes promot
247 lammation stage of murine wound healing, and bone marrow-derived cells served as a major source of LR
248 ponses seen in C57BL/6 mice was dependent on bone marrow-derived cell-specific expression of tlr4, an
249 ion of MCP-1, which is a chemoattractant for bone marrow-derived cells, specifically MSC.
250 he results indicate that A2AAR activation on bone marrow-derived cells, specifically T or B lymphocyt
251 ytes/macrophages, these actors are joined by bone marrow-derived cells, such as eosinophils and mast
252 termined that sarcomas do not originate from bone marrow-derived cells, such as macrophages, but aris
253 dent upon IL-1R/MyD88 signaling by recruited bone marrow-derived cells, suggesting that resident skin
254  cognate interactions with CD 1 d-expressing bone marrow-derived cells that are both necessary and su
255                   Fibrocytes are circulating bone marrow-derived cells that have been implicated in t
256          Here we have isolated E2A-deficient bone marrow-derived cells that have the ability to grow
257 mber of endothelial progenitor cells (EPCs), bone marrow-derived cells that participate in endothelia
258 1(+)CD11b(+) myeloid cells are heterogeneous bone marrow-derived cells that promote inflammation-asso
259 (+) myeloid cells constitute a population of bone marrow-derived cells that promote tumor progression
260                               Similarly, the bone-marrow-derived cell that might most effectively eng
261                            In conclusion, in bone marrow-derived cells the nuclear receptor Nur77 has
262                         In contrast, another bone marrow-derived cell, the T lymphocyte, although cap
263 pression was necessary and sufficient in the bone marrow-derived cells themselves to promote tumor fo
264      Pioneering clinical trials suggest that bone marrow-derived cell therapy enhances neovasculariza
265      One such strategy is the utilization of bone marrow-derived cell therapy.
266 rieties of subsets of immune cells and other bone marrow-derived cells to atherogenesis.
267 he current understanding of contributions of bone marrow-derived cells to atherosclerosis.
268 ent, there was no detectable contribution of bone marrow-derived cells to either skeletal muscle or m
269  parabiosis to introduce fluorescent-labeled bone marrow-derived cells to mice with intestinal tumors
270  across 136,463 resting and stimulated human bone marrow-derived cells to reveal changes in the cis-
271 tagonists effectively prevented targeting of bone marrow-derived cells to the developing retinal vasc
272           To investigate the contribution of bone marrow-derived cells to the formation of tumor vess
273 ling and suppressed the recruitment of these bone marrow-derived cells to the lung.
274  plays a critical role in the recruitment of bone marrow-derived cells to the tumor microenvironment
275  a relative reduction in the contribution of bone marrow-derived cells to tumor stroma.
276 F agonists, which then act on PAF-R-positive bone marrow-derived cells to upregulate IL-10 through CO
277 patic metastasis by enhancing recruitment of bone-marrow-derived cells to the metastatic site.
278 ung cancer cells use caveolin-2 expressed in bone marrow-derived cell types including TAMs to promote
279 fibrosis outside the CNS have identified two bone marrow-derived cell types, fibrocytes and alternati
280  mice with green fluorescent protein-labeled bone marrow-derived cells underwent corneal scrape injur
281                 Adoptive transfer of labeled bone marrow-derived cells validated the results in a mur
282 l, we determined that expression of NLRP3 in bone marrow-derived cells was necessary for optimal tumo
283  in vessel size, whereas MyD88 expression by bone marrow-derived cells was obligatory for changes in
284 titis revealed that expression of P2Y(2)R in bone marrow-derived cells was required for liver infiltr
285 ce ANAs, and that lack of H2-O expression in bone marrow-derived cells was sufficient to induce the a
286 aracterizing the composition of infiltrating bone marrow-derived cells, we identified CD11b+/Ly6Cmed/
287 e appearance of these cell types and whether bone marrow-derived cells were capable of acquiring fibr
288 d, approximately 99% of all tumor-associated bone marrow-derived cells were CD45(+) hematopoietic cel
289  and the differentiation of osteoclasts from bone marrow-derived cells were completely suppressed by
290 in the vascular endothelium, indicating that bone marrow-derived cells were not recruited to endothel
291                             Immune cells and bone marrow-derived cells were not required for aggressi
292 TLR4 mutant mice transplanted with their own bone marrow-derived cells were protected from hepatic I/
293                    In these situations, host bone marrow-derived cells were the key source of the IL-
294 ), VEGFR2(+)/CD34(+), and VEGFR2(+)/CD117(+) bone-marrow derived cells were increased in the peripher
295 ancing airway epithelial remodeling by adult bone marrow-derived cells will be necessary for correcti
296      Historically, SSCs have been defined as bone marrow-derived cells with inconsistent characterist
297                      EphA3 is found on mouse bone marrow-derived cells with mesenchymal and myeloid p
298 isite localization of various populations of bone marrow-derived cells with respect to the vasculatur
299 or-antigen presentation to immune T cells by bone-marrow-derived cells within the tumor microenvironm
300                          COX-1 deficiency in bone marrow-derived cells worsens early atherosclerosis

 
Page Top